Athena Global Technologies Limited announced its Q3FY26 financial results for the quarter ended December 31, 2025, demonstrating a remarkable turnaround with standalone profit of ₹348.36 lakhs compared to losses in previous quarters. The company's board meeting held on February 14, 2026, also approved significant strategic decisions including management re-appointment and fund raising initiatives through warrant issuance.

Q3FY26 Financial Performance

The company's standalone financial results show mixed performance with revenue declining quarter-over-quarter but achieving profitability after consecutive loss-making quarters. The significant improvement in profitability was primarily driven by substantial other income of ₹2,434.88 lakhs.

Consolidated Results and Segment Performance

The consolidated financial results reflect total revenue of ₹2,572.64 lakhs for Q3FY26 with profit before tax of ₹931.12 lakhs. The company operates across multiple business segments with leasing activity contributing the highest revenue.

Board Decisions and Strategic Initiatives

The board meeting resulted in key corporate governance decisions and fund raising proposals. Directors approved the re-appointment of the Managing Director for a three-year term and considered warrant issuance to promoter group members.

Fund Raising Through Warrants

The company's board approved a preferential allotment of up to 7,00,000 fully convertible equity share warrants of ₹10 each to promoter group members. Mr. Karthikeya Manchala's shareholding would increase from 6,50,000 shares (4.42%) to 13,50,000 shares (8.75%) post-conversion. The initiative requires shareholder approval and regulatory clearances as per SEBI ICDR Regulations 2018.

Key Financial Highlights

Other income includes significant components such as accrued interest of ₹38.56 lakhs on loans to subsidiary Medley Medical Solutions and ₹42.90 lakhs to Tutoroot Technologies. Additionally, other income includes profit of ₹2,339.75 lakhs on derecognition of investment property through perpetual lease execution. The financial results have been reviewed by statutory auditors Ramanatham & Rao in accordance with Standard on Review Engagements (SRE) 2410 and approved by the audit committee and board of directors.

Athena Global Technologies Limited has announced its financial results for the first quarter ended June 30, along with significant corporate actions. The company's Board of Directors approved both standalone and consolidated unaudited financial results at a meeting held on August 11.

Financial Performance

The company's consolidated results include its subsidiaries Medley Medical Solutions Private Limited, Tutoroot Technologies Private Limited, and Athena Inc. The performance of these subsidiaries for the quarter was as follows:

Warrant Conversion

In a significant move, Athena Global Technologies has converted 6,50,000 share warrants into equity shares. These warrants were originally allotted to Mr. Karthikeya Manchala on February 12, 2024. The conversion price was set at ₹87 per share, which includes a premium of ₹77 over the face value of ₹10 per share.

Fund Utilization

The company had previously raised ₹5.65 crore through a preferential issue of share warrants. As of June 30, Athena Global Technologies has received ₹1.41 crore as an upfront payment, representing 25% of the total warrant amount. The funds are allocated for various purposes including:

1. Long-term capital requirements for future growth
2. Working capital needs
3. Debt reduction
4. General corporate purposes

Regulatory Compliance

The company has submitted its financial results in compliance with Regulations 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Independent auditors have reviewed both the standalone and consolidated financial results, finding no material misstatements or deviations from accounting standards.

Athena Global Technologies continues to focus on its growth strategy, utilizing the funds raised to strengthen its financial position and support its operational needs. The conversion of warrants into equity shares demonstrates investor confidence in the company's future prospects.